Autopsy report · NCT00482287

Pharmacokinetics and Pharmacodynamics of MTR105 in Hypotensive Cardiac Surgery Patients

“Site did not recruit any patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Meditor Pharmaceuticals Ltd.

Sponsor type

Industry

Conditions

Hypotension; Cardiopulmonary Bypass

Interventions

MTR105

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
  “not able to recruit patients” (81% match in meaning)
• Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases
  “unable to recruit patients” (81% match in meaning)
• Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow
  “no recruited patients” (77% match in meaning)
• Radical Lung Radiotherapy Plus Nelfinavir
  “failed to recruit, no suitable patients” (77% match in meaning)
• Bone Healing in Healthy and Post-menopausal Osteoporotic Women
  “Unable to recruit suitable patients” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.